Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M24,368Revenue $M1,212Net Margin (%)-56.9Z-Score12.2
Enterprise Value $M23,667EPS $-2.0Operating Margin %-97.1F-Score2
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-103.7Higher ROA y-yN
Price/Book20.610-y EBITDA Growth Rate %0Quick Ratio3.7Cash flow > EarningsY
Price/Sales28.65-y EBITDA Growth Rate %0Current Ratio3.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-20.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-37.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M238ROI % (ttm)-31.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 102.3547%New holding, 6753 sh.6,753
VRTXJohn Burbank 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 102.3547%Sold Out0
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 102.3547%Sold Out0
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 102.3529%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 102.3529%New holding, 10000 sh.10,000
VRTXJohn Burbank 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 102.3529%New holding, 2872 sh.2,872
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 102.3547%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 102.3528%Add 19%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 102.3539%Add 140.58%5,990,000
VRTXAndreas Halvorsen 2013-06-30 Sold Out -0.26%$52.6 - $85.6
($73.64)
$ 102.3539%Sold Out0
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 102.3539%Sold Out0
VRTXAndreas Halvorsen 2013-03-31 Buy 0.26%$41.9 - $54.97
($47.91)
$ 102.35114%New holding, 780500 sh.780,500
VRTXNWQ Managers 2013-03-31 Reduce-0.02%$41.9 - $54.97
($47.91)
$ 102.35114%Reduce -23.44%191,032
VRTXDaniel Loeb 2012-12-31 Sold Out -0.77%$38.88 - $59.42
($46.08)
$ 102.35122%Sold Out0
VRTXJohn Burbank 2012-12-31 Sold Out -0.38%$38.88 - $59.42
($46.08)
$ 102.35122%Sold Out0
VRTXDaniel Loeb 2012-09-30 Add0.22%$48.38 - $59.07
($53.5)
$ 102.3591%Add 40%700,000
VRTXJohn Burbank 2012-09-30 Reduce-0.09%$48.38 - $59.07
($53.5)
$ 102.3591%Reduce -25%150,000
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 102.3591%Sold Out0
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 102.3591%Sold Out0
VRTXDaniel Loeb 2012-06-30 Buy 0.85%$35.75 - $65.62
($50.92)
$ 102.35101%New holding, 500000 sh.500,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRTX Ken Fisher 2014-06-306,75300New Buy
VRTX Vanguard Health Care Fund 2014-06-3011,807,5004.962.9+1.54%
VRTX John Burbank 2014-06-30000Sold Out
VRTX George Soros 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2014-10-15Sell5,700$101.470.87view
Silva Paul MSVP & Corp Controller 2014-10-13Sell1,125$107.89-5.13view
Chodakewitz JeffreyEVP GMDA, CMO 2014-10-07Sell3,436$104.26-1.83view
ALTSHULER DAVIDDirector 2014-10-06Sell1,405$109.75-6.74view
ULLIAN ELAINEDirector 2014-10-01Sell5,000$107.74-5view
Connolly ThomasSVP, Human Resources 2014-10-01Sell750$108.12-5.34view
BOGER JOSHUA SDirector 2014-10-01Sell5,700$107.29-4.6view
Arbuckle Stuart AEVP\Chief Commercial Officer 2014-10-01Sell12,417$107.71-4.98view
ALTSHULER DAVIDDirector 2014-10-01Sell10,595$107.74-5view
LEIDEN JEFFREY MCEO & President 2014-09-30Sell200,000$112.69-9.18view

Press Releases about VRTX :

Quarterly/Annual Reports about VRTX:

News about VRTX:

Articles On GuruFocus.com
Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 
Achillion Will Surge If New Drug Is Successful Apr 21 2012 
Columbia Management Fourth Quarter Letter with Comments on SWK, AGCO, CE, MCP, VRTX, DOLE, F, HAS, A Apr 10 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 


More From Other Websites
Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer Oct 15 2014
Vertex to Announce Third Quarter 2014 Financial Results on October 28 Oct 14 2014
Bank Of America Is Impressed By Takeaways From Vertex Pharmaceuticals Conference Call Oct 14 2014
3 Stocks Improving Performance Of The Drugs Industry Oct 13 2014
UPDATE: Piper Jaffray Upgrades Vertex Pharmaceuticals Ahead Of Expected Combination Approvals Oct 13 2014
Vertex Pharmaceuticals (VRTX) Updates on Kalydeco Studies Oct 10 2014
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple... Oct 09 2014
Why You Shouldn't Bet Against Vertex Pharmaceuticals (VRTX) Stock Oct 09 2014
Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update Oct 08 2014
Better-than-expected jobs data helped benchmarks end in the green on Friday Oct 06 2014
Johnson & Johnson Bets $1.75 Billion On Alios Buy Sep 30 2014
[video] Q4 momentum Sep 30 2014
Q4 momentum Sep 30 2014
Today's Market Thorns, Roses, and All Time Highs... Sep 29 2014
Today's Market Thorns, Roses, and All Time Highs... Sep 26 2014
3 Drugs Stocks Driving The Industry Higher Sep 26 2014
Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios Sep 26 2014
[video] Fast Money Final Trade: PFE, DOW, VRTX & the dollar Sep 25 2014
Fast Money Final Trade: PFE, DOW, VRTX & the dollar Sep 25 2014
Today's Market Thorns, Roses, and All Time Highs... Plus an Extra... Sep 25 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK